Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Castor oil plus low-dose PEG versus standard-dose PEG for colonoscopy bowel preparation
ChiCTR-IIR-17012418Phase 3Not yet recruiting
- Sponsor
- Chongqing University Cancer Hospital
- Start
- Sep 2017
- Modality
- Small Molecules, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of macrogol, Castor oil and ascorbic acid in bowel preparation (3 arms), sponsored by Chongqing University Cancer Hospital. Primary endpoint: Bowel preparation efficacy. Planned start Sep 2017; status: not yet recruiting.
02
Drugs
macrogolCastor oilascorbic acid
03
Conditions
bowel preparation
Beyond the preview
Go deeper on ChiCTR-IIR-17012418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IIR-17012418.